Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell Lymphomas
Clinical trial NCT02488512 · TERMINATED
Trial details
- NCT number
- NCT02488512
- Sponsor
- Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2018-02-23
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.